CarnoSyn® Brands to Showcase TriBsyn™ at 46th ESPEN Congress on Clinical Nutrition and Metabolism

CARLSBAD, Calif., August 26, 2024 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (NAI) and CarnoSyn^® Brands will exhibit at the 46th edition^and ESPEN Congress on Clinical Nutrition and Metabolism in Milan, Italy, from 7 to 10 September 2024. ESPEN 2024 offers companies a unique platform to present and educate about innovative science in the field of clinical nutrition and metabolism. The congress encourages collaboration with physicians, dietitians, pharmacists, nutritionists, scientists and nurses.

The NAI and CarnoSyn^® The Brands team will be on hand at booth #16 to discuss the latest clinical evidence of TriBsyn™, a patent-pending formulation that utilizes proprietary technology to increase the bioavailability and absorption of beta-alanine while effectively eliminating the common paresthesia sensation associated with effective doses of beta-alanine. TriBsyn™ represents a new opportunity to reach untapped consumers, from seniors to vegans and anyone focused on wellness. Conference attendees are invited to visit the booth to learn more about this new product innovation.

Aaron Starr, Vice Chairman, CarnoSyn^® Brands stated, “We are excited to exhibit TriBsyn™ at this year’s ESPEN Congress on Clinical Nutrition and Metabolism and share details about the clinically proven formula. There is an evolving need and growing demand for healthy aging and wellness solutions, and this patented carnosine booster is a game changer for dietary supplement categories, as well as fortified and medical foods, that target muscle vitality, cognitive performance and anti-aging support.”

After ESPEN the team will attend the 20th edition^and European Geriatric Medicine Society (EuGMS) Congress in Valencia, Spain, from 18 to 20 September.

Learn more about TriBsyn™ by visiting ESPEN booth #16 or www.tribsyn.com.

About CarnoSyn^® To notice:
CarnoSyn^® Brands contain three clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn^® immediate release beta-alanine powder, SR CarnoSyn^® beta-alanine delayed release tablets and TriBsyn™ powder. In 2019, CarnoSyn^® beta-alanine has successfully obtained NDI status from the FDA and received Self-Affirmed GRAS (Generally Recognized as Safe) status. SR CarnoSyn^®an advanced dosage form of CarnoSyn^®received GRAS validation in 2017. The new “paresthesia-free” TriBsyn™ powder enables NAI to expand their product offering within the dietary supplement category, including medical and other fortified nutritional products. Want to learn more about SR CarnoSyn?^® in active nutrition and wellness, visit www.srcarnosyn.com. For more information on the latest innovation, TriBsyn™, visit www.tribsyn.com.

About NAI:
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of dietary supplements and provides strategic partnering services to its clients. NAI’s comprehensive partnership approach provides a broad range of innovative nutritional products and services to clients, including scientific research, proprietary ingredients, customized nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, visit www.nai-online.com.

Contact:
Renee Michaelson
Director of Global Marketing
NAI/CarnoSyn^® To notice
(760) 736-7700
[email protected]